In line with this, we observed an increase of the autophagy marker LC3-II in MCL cell line Mino upon co-treatment of bortezomib with palbociclib or after treatment with palbociclib alone (Fig. 2b, upper panel). Here, MAP1LC3A is linked to mantle cell lymphoma.